Viewing Study NCT00129168


Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2025-12-28 @ 4:29 AM
Study NCT ID: NCT00129168
Status: COMPLETED
Last Update Posted: 2008-04-01
First Post: 2005-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)
Sponsor: Kanisa Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module References Module